3-Methyladenine can depress drug efflux transporters via blocking the PI3K–AKT–mTOR pathway thus sensitizing MDR cancer to chemotherapy

Genomics and Cancer Drug Resistance

(2012) Antonio S. Rodrigues et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

Rifampicin-Independent Interactions between the Pregnane X Receptor Ligand Binding Domain and Peptide Fragments of Coactivator and Corepressor Proteins

(2011) Punya Navaratnarajah et al.   BIOCHEMISTRY

MicroRNA-30a Sensitizes Tumor Cells to cis-Platinum via Suppressing Beclin 1-mediated Autophagy

(2011) Zhenyou Zou et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

PI3K pathway inhibitors approach junction

(2011) David Holmes   NATURE REVIEWS DRUG DISCOVERY

Finding a fitting shoe for Cinderella

(2010) Simon Miller et al.   Autophagy

Over-expression of MDR1 in amrubicinol-resistant lung cancer cells

(2010) Osamu Takakuwa et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Dual Role of 3-Methyladenine in Modulation of Autophagy via Different Temporal Patterns of Inhibition on Class I and III Phosphoinositide 3-Kinase

(2010) You-Tong Wu et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Ageing, the Urban-Rural Gap and Disability Trends: 19 Years of Experience in China - 1987 to 2006

(2010) Xiaoxia Peng et al.   PLoS One

Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells

(2008) Hua Zhu et al.   BIOCHEMICAL PHARMACOLOGY